Tumor News and Research

RSS

50 U.S. Hospitals approve Osteotech's Plexur M bone-polymer biocomposite

Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that Plexur M® (moldable), a bone-polymer biocomposite built upon the Company's proprietary Plexur® technology platform, has been approved for use by 50 U.S. hospitals to date. The Company expects to receive additional approvals as Plexur M continues to gain mindshare among surgeons.

1 Dec 2009

Varian Medical Systems' RapidArc radiotherapy enables faster stereotactic treatment of lung tumors

Researchers from VU University Medical Center in Amsterdam have reported that RapidArc® radiotherapy from Varian Medical Systems has clinical advantages over earlier fixed-beam approaches to stereotactic treatments of lung tumors. Their findings, based on treatment of 85 medically inoperable lung cancer patients, were reported at the recent annual meeting of the American Society for Radiation Oncology (ASTRO) in Chicago and a condensed version has been published in the 'Green Journal' (Radiotherapy and Oncology) 93 (2009).

1 Dec 2009

MAbs for early detection of cancer

Two sets of recommendations issued earlier this month have revised longstanding guidelines concerning the age at which women should first be tested for breast and cervical cancer and how frequently.

1 Dec 2009

Researchers devise a way to deliver right therapy directly to tumors using aptamers

Finding and treating a tumor without disturbing normal tissue presents challenges - sometimes the most effective therapies can be invasive and harsh.

1 Dec 2009

High-frequency ultrasound with elastography improves skin cancer diagnosis

High-frequency ultrasound with elastography can help differentiate between cancerous and benign skin conditions, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

1 Dec 2009

Low-dose radiation increases breast cancer risk in high-risk women

Low-dose radiation from annual mammography screening may increase breast cancer risk in women with genetic or familial predisposition to breast cancer, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

1 Dec 2009

BSGI proves to be an effective adjunct imaging modality for detecting DCIS

Breast-Specific Gamma Imaging (BSGI) has been proven to be a highly sensitive imaging technique for the detection of ductal carcinoma in situ (DCIS), a difficult to diagnose breast cancer. BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers.

30 Nov 2009

MagForce Nanotechnologies initiates conformity assessment procedure for its Nano-Cancer therapy

MagForce Nanotechnologies AG has submitted the product file for NanoTherm® to Medcert GmbH, the medical certification and testing company which serves as Notified Body for the certification of medical products. With this step, MagForce has now commenced the conformity assessment procedure for its Nano-Cancer ® therapy.

30 Nov 2009

Spectrum Pharmaceuticals completes enrollment in apaziquone Phase 3 trial

Spectrum Pharmaceuticals today announced that one of the two Phase 3 pivotal clinical trials of apaziquone has achieved its enrollment target, having enrolled approximately 800 patients with non-invasive bladder cancer. The second Phase 3 clinical trial of apaziquone is expected to complete enrollment by the end of the year.

30 Nov 2009

Siemens Healthcare to showcase latest medical imaging technologies at RSNA 2009

At the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), "Images, my way" will resonate throughout the Siemens Healthcare booth (#825) from November 29 to December 3 at McCormick Place (Booth #825, East Building/Lakeside Center, Hall D) in Chicago.

30 Nov 2009

Cell Therapeutics' platinum-based anti-tumor compounds demonstrate stronger anti-tumor potency

Cell Therapeutics, Inc. (CTI) announced today that its new class of platinum-based anti-tumor compounds, termed bis-platinates, demonstrated a stronger anti-tumor potency and activity compared to currently available platinum-based compounds as well as the ability to overcome cisplatin-resistance in cancer cell lines.

30 Nov 2009

Siemens Healthcare to introduce high-end imaging systems for interventional oncological procedures at RSNA 2009

At the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from November 29 to December 3 at McCormick Place in Chicago, Siemens Healthcare will introduce its comprehensive portfolio for imaging in interventional oncology at booth #825, East Building/Lakeside Center, Hall D.

30 Nov 2009

Copper sequestering drug tetrathiomolybdate shown to be effective in treating Wilson disease

The copper sequestering drug tetrathiomolybdate (TM) has been shown in studies to be effective in the treatment of Wilson disease, a disease caused by an overload of copper, and certain metastatic cancers.

27 Nov 2009

Wnt signaling pathway plays a role in diabetic retinopathy

A group led by Dr. Jian-xing Ma at The University of Oklahoma Health Sciences Center, Oklahoma City, OK has demonstrated that the Wnt signaling pathway plays a role in diabetic retinopathy.

26 Nov 2009

Wnt and EGFR signaling pathways interact to promote tumor cell invasion and metastasis

Two signaling pathways essential to normal human development - the Wnt/Wingless (Wnt) and epidermal growth factor receptor (EGFR) pathways - interact in ways that can promote tumor cell invasion and metastasis, researchers from The University of Texas M. D. Anderson Cancer Center report in the Nov. 25 issue of Molecular Cell.

26 Nov 2009

Three high risk indicators that aid mammography screening

Mammography Reporting System, Inc. (MRS) will demonstrate their newest high risk indicator at RSNA 2009, in Chicago. MRS is the only company in the industry offering three separate high risk indicators to alert radiologists of potentially at-risk patients at the very point they interpret a mammogram.

26 Nov 2009

TomTec Imaging Systems to present new technology for radiologic ultrasound at upcoming RSNA conference

TomTec Imaging Systems, the leading innovator for cardiac image analysis and image management will present its new technology for radiologic ultrasound at the upcoming RSNA conference in Chicago.

26 Nov 2009

Dr. Sarit Larisch receives the prestigious Johnson & Johnson Focused Funding grant

Dr. Sarit Larisch, Head of the Cell Death Research Laboratory in the University of Haifa's Department of Biology, has been awarded the prestigious Johnson & Johnson Focused Funding grant for her research exploring the cause of brain cell damage in Parkinson's disease.

26 Nov 2009

Aegis Breast 3.0 that offers powerful real-time 4D image processing to be launched

Sentinelle Medical Inc., a leading manufacturer of breast MRI coils and advanced visualization software launches a suite of new leading edge clinical applications on its Aegis(TM) medical imaging software platform at this year's Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 30 - Dec. 5, 2009 (Booth 5800, Hall A).

26 Nov 2009

Roche's xCELLigence RTCA DP Instrument with CIM-Plate 16 enables real-time monitoring of cell migration

Cell migration is an important process in the development of organisms, as well as during immune surveillance and wound healing. For cancer development, the potential of cells to migrate or to grow invasively is, in addition to proliferation, the most important disease-causing factor. The inhibition of cell migration is a key target of the new anti-inflammatory therapies.

25 Nov 2009

Tumor News and Research

50 U.S. Hospitals approve Osteotech's Plexur M bone-polymer biocomposite

Varian Medical Systems' RapidArc radiotherapy enables faster stereotactic treatment of lung tumors

MAbs for early detection of cancer

Researchers devise a way to deliver right therapy directly to tumors using aptamers

High-frequency ultrasound with elastography improves skin cancer diagnosis

Low-dose radiation increases breast cancer risk in high-risk women

BSGI proves to be an effective adjunct imaging modality for detecting DCIS

MagForce Nanotechnologies initiates conformity assessment procedure for its Nano-Cancer therapy

Spectrum Pharmaceuticals completes enrollment in apaziquone Phase 3 trial

Siemens Healthcare to showcase latest medical imaging technologies at RSNA 2009

Cell Therapeutics' platinum-based anti-tumor compounds demonstrate stronger anti-tumor potency

Siemens Healthcare to introduce high-end imaging systems for interventional oncological procedures at RSNA 2009

Copper sequestering drug tetrathiomolybdate shown to be effective in treating Wilson disease

Wnt signaling pathway plays a role in diabetic retinopathy

Wnt and EGFR signaling pathways interact to promote tumor cell invasion and metastasis

Three high risk indicators that aid mammography screening

TomTec Imaging Systems to present new technology for radiologic ultrasound at upcoming RSNA conference

Dr. Sarit Larisch receives the prestigious Johnson & Johnson Focused Funding grant

Aegis Breast 3.0 that offers powerful real-time 4D image processing to be launched

Roche's xCELLigence RTCA DP Instrument with CIM-Plate 16 enables real-time monitoring of cell migration

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News